Genomic imprinting variations in the mouse type 3 deiodinase gene between tissues and brain regions

Molecular Endocrinology

Volumn 28, Issue 11, 2014, Pages 1875-1886

  Elena Martinez, M ^a   Charalambous, Marika ^b   Saferali, Aabida ^c   Fiering, Steven ^d   Naumova, Anna K ^c   Germain, Donald St ^a   Ferguson Smith, Anne C ^e   Hernandez, Arturo ^a  

^a Maine Medical Center Research Institute   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEIODINASE TYPE 3; MESSENGER RNA; THYROXINE DEIODINASE; TRANSCRIPTION FACTOR CTCF; UNCLASSIFIED DRUG; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE III; THYROID HORMONE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DNA METHYLATION; EMBRYO; EPIGENETICS; EYE; FEMALE; FETUS; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; GENOME IMPRINTING; GENOTYPE; HAPLOINSUFFICIENCY; HIPPOCAMPUS; HOMOLOGOUS RECOMBINATION; HYPOTHALAMUS; INTRON; MALE; MESENCEPHALON; MOUSE; NEOCORTEX; NEWBORN; NONHUMAN; PHENOTYPE; PHENOTYPIC VARIATION; PONS; PROMOTER REGION; PROTEIN DOMAIN; TESTIS; TISSUE SPECIFICITY; ANIMAL; BRAIN; C57BL MOUSE; CELL LINE; GENETICS; METABOLISM; METHYLATION;

ALLELES; ANIMALS; BRAIN; CELL LINE; FEMALE; GENOMIC IMPRINTING; IODIDE PEROXIDASE; METHYLATION; MICE; MICE, INBRED C57BL; PHENOTYPE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; THYROID HORMONES;

EID: 84908324582     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1210     Document Type: Article

References (46)

1. Kohrle J. Iodothyronine deiodinases. Methods Enzymol. 2002;347: 125–167.
2. Hernandez A. Structure and function of the type 3 deiodinase gene. Thyroid. 2005;15:865–874.
3. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002; 23:38–89.
4. Huang SA, Dorfman DM, Genest DR, Salvatore D, Larsen PR. Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab. 2003;88:1384–1388.
5. Galton VA, Martinez E, Hernandez A, St Germain EA, Bates JM, St Germain D.. Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase. J Clin Invest. 1999;103:979–987.
6. Kaplan MM, Yaskoski KA. Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates. J Clin Invest. 1980;66: 551–562.
7. Tu HM, Legradi G, Bartha T, Salvatore D, Lechan R, Larsen PR. Regional expression of the type 3 iodothyronine deiodinase mes-senger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology. 1999;140:784-790.
8. Hernandez A, Martinez ME, Fiering S, Galton VA, St Germain D. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest. 2006;116:476-484.
9. Hernandez A, Martinez E, Liao X, et al Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis. Endocrinology. 2007;148:5680-5687.
10. Ueta CB, Oskouei BN, Pinto JR, et al. Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice. Mol Endocrinol. 2012;26:809-818.
11. Ng L, Hernandez A, He W, et al. A protective role for type 3 deiodinase, a thyroid hormone-inactivating enzyme, in cochlear development and auditory function. Endocrinology. 2009;150: 1952-1960.
12. Ng L, Lyubarsky A, Nikonov SS, et al. Type 3 deiodinase, a thyroid-hormone inactivating enzyme, controls survival and maturation of cone photoreceptors. J Neuroscience. 2010;30:3347-3357.
13. Medina MC, Molina J, Gadea Y, et al. The thyroid hormone-inactivating type III deiodinase is expressed in mouse and human β-cells and its targeted inactivation impairs insulin secretion. Endocrinology. 2011;152:3717-3727.
14. Hernandez A, Quignodon L, Martinez ME, Flamant F, St Germain DL. Type 3 deiodinase deficiency causes spatial and temporal alterations in brain T3 signaling that are dissociated from serum thyroid hormone levels. Endocrinology. 2010;151:5550-5558.
15. Hernandez A, Morte B, Belinchon MM, Ceballos A, Bernal J. Critical role of type 2 and 3 deiodinases in negative regulation of gene expression by T3 in the brain. Endocrinology. 2012;153(6):2919-2928.
16. Tsai C, Lin SP, Ito M, Takagi N, Takada S, Ferguson-Smith AC. Genomic Imprinting contributes to thyroid hormone metabolism in the mouse embryo. Curr Biol. 2002;12:1221-1226.
17. Hernandez A, Fiering S, Martinez E, Galton VA, St Germain D. The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts. Endocrinology. 2002;143:4483-4486.
18. Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet. 2001;2:21-32.
19. Ferguson-Smith AC. Genomic imprinting: the emergence of an epi-gentic paradigm. Nat Rev Genet. 2011;12(8):565-575.
20. Brannan CI, Bartolomei MS. Mechanisms of genomic imprinting. Curr Opin Genet Dev. 1999;9:164-170.
21. Georgiades P, Watkins M, Surani MA, Ferguson-Smith AC. Parental origin-specific developmental defects in mice with uniparental disomy for chromosome 12. Development. 2000;127(21):4719-4728.
22. Cleaton MAM, Edwards CA, Ferguson-Smith AC. Phenotypic outcomes of imprinted gene models in mice: elucidation of pre- and postnatal functions of imprinted genes. Annu Rev Genom Hum Genet. 2014;15:93-126.
23. Falls JG, Pulford DJ, Wylie AA, Jirtle RL. Genomic imprinting: implications for human disease. Am J Pathol. 1999;154:635-647.
24. Ohta T, Gray TA, Rogan PK, et al. Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet. 1999;64:397-413.
25. Fang P, Lev-Lehman E, Tsai TF, et al. The spectrum of mutations in UBE3A causing Angelman syndrome. Hum Mol Genet. 1999;8: 129-135.
26. Maher ER, Reik W. Beckwith-Wiedemann syndrome: imprinting in clusters revisited. J Clin Invest. 2000;105:247-252.
27. Temple IK, Cockwell A, Hassold T, Pettay D, Jacobs P. Maternal uniparental disomy for chromosome 14. J Med Genet. 1991;28: 511-514.
28. da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC. Genomic imprinting at the mammalian Dlk1-Dio3 domain. (Review, 85 references). Trends Genet. 2008;24(6):306-316.
29. Lin SP, Coan P, da Rocha ST, et al. Differential regulation of imprinting in the murine embryo and placenta by the Dlk1-Dio3 imprinting control region. Development. 2007;134(2):417-426.
30. Paxinos G, Franklin KBJ 1997 The mouse brain in stereotaxic coordinates. 2013 Fourth Edition. London, Academic Press.
31. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. Derivation of completely cell culture-derived mice from early passage embryonic stem cells. ProcNatlAcad Sci USA. 1993;90:8424-8428.
32. Galton VA, Hiebert A. Hepatic iodothyronine 5-deiodinase activity in Rana catesbeiana tadpoles at different stages of the life cycle. Endocrinology. 1987;121:42-47.
33. Takada S, Paulsen M, Tevendale M, et al. Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: implications for imprinting control from comparison with Igf2-H19. Hum Mol Genet. 2002;11:77-86.
34. Sun B, Ito M, Brions IG, et al. Status of genomic imprinting in epigenetically distinct pluripotent stem cells. Stem Cells. 2012;30: 161-168.
35. Kuiper GG, Klootwijk W, Visser TJ. Substitution of cysteine for selenocysteine in the catalytic center of type III iodothyronine deiodinase reduces catalytic efficiency and alters substrate preference. Endocrinology. 2003;144:2505-2513.
36. Lin SP, Youngson N, Takada S, et al. Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. Nat Genet. 2003; 35:97-102.
37. Croteau S, Roquis D, Charron MC, et al. Increased plasticity of genomic imprinting of Dlk1 in brain is due to genetic and epigenetic factors. Mamm Genome. 2005;16:127-135.
38. Habib O, Habib G, Moon SH, et al. Ground-state conditions promote robust Prdm14 reactivation and maintain and active Dlk1-Dio3 region during reprogramming. Mol Cells. 2014;37:31-35.
39. Allshire R, Bickmore W. Pausing for thought on the boundaries of imprinting. Cell. 2000;102:705-708.
40. Arnaud P, Monk D, Hitchins M, et al. Conserved methylation imprints in the human and mouse GRB10 genes with divergent allelic expression suggests differential reading of the same mark. Hum Mol Genet. 2003;12:1005-1019.
41. Plagge A, Kelsey G. Imprinting the Gnas locus. Cytogenet Genome Res. 2006;113:178-187.
42. Lu A, Ng L, Ma M, et al. Retarded developmental expression and patterning of retinal cone opsins in hypothyroid mice. Endocrinology. 2009;150:1536-1544.
43. Ferron SR, Charalambous M, Radford E, et al. Postnatal loss of Dlk1 imprinting in stem cells and niche astrocytes regulates neurogenesis. Nature. 2011;475:381-385.
44. Dentice M, Luongo C, Huang S, et al. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Nat Acad Sci USA. 2007;104:14466-14471.
45. Sittig LJ, Shukla PK, Herzing LB, Redei EE. Strain-specific vulnerability to alcohol exposure in utero via hippocampal parent-of-origin expression of deiodinase-III. FASEB J. 2011;25:2313-2324.
46. Correa MC, Fonseca T, Molina J, et al. Maternal inheritance of an inactive type III deiodinase gene affects mouse pancreatic β-cells and disrupts glucose homeostasis. Endocrinology. 2014; 155: 3160-3171.